• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(±)-耳蜗醇T、(±)-灵芝耳蜗素A和(±)-耳蜗醇Y的化学合成及抗纤维化特性

Chemical Synthesis and Antifibrotic Properties of (±)-Cochlearol T, (±)-Ganocochlearin A, and (±)-Cochlearol Y.

作者信息

Kakde Badrinath N, An Sung Wan, Jebaraj Yaashmin Shiny, Neelam Sudha, Wolf Matthias T F, Tambar Uttam K

机构信息

Department of Biochemistry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States.

Department of Pediatrics, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9063, United States.

出版信息

ACS Med Chem Lett. 2024 Nov 12;15(12):2220-2224. doi: 10.1021/acsmedchemlett.4c00497. eCollection 2024 Dec 12.

DOI:10.1021/acsmedchemlett.4c00497
PMID:39691537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11647713/
Abstract

The cochlearols and ganocochlearins are natural products with unique antifibrotic and renoprotective activities in models of kidney disease. They represent compelling lead compounds for pharmacological intervention against kidney disease, often characterized by renal fibrosis. We report a four-step synthesis of (±)-cochlearol T () and the first reported syntheses of (±)-ganocochlearin A () and (±)-cochlearol Y () through a strategy that includes a Robinson annulation and unexpected oxidative aromatization. We also access tricyclic intermediate that represents a formal synthesis of ganocins A-C and ganocochlearins C-D. We investigated the activity of these synthesized compounds by inducing fibrosis in a human kidney cell line with TGF-β1. The effect on fibrosis was assessed by qPCR and Western blot studies. We detected significantly lower mRNA gene and protein expression of fibrosis markers for all three natural products.

摘要

耳蜗醇类和甘诺耳蜗素类是在肾脏疾病模型中具有独特抗纤维化和肾脏保护活性的天然产物。它们是针对通常以肾纤维化为特征的肾脏疾病进行药物干预的极具吸引力的先导化合物。我们报道了通过包括罗宾逊环化反应和意外氧化芳构化反应的策略,对(±)-耳蜗醇T()进行的四步合成,以及首次报道的(±)-甘诺耳蜗素A()和(±)-耳蜗醇Y()的合成。我们还获得了三环中间体,该中间体代表了对甘诺菌素A-C和甘诺耳蜗素C-D的形式合成。我们通过用TGF-β1诱导人肾细胞系纤维化来研究这些合成化合物的活性。通过qPCR和蛋白质印迹研究评估对纤维化的影响。我们检测到所有三种天然产物的纤维化标志物的mRNA基因和蛋白质表达均显著降低。

相似文献

1
Chemical Synthesis and Antifibrotic Properties of (±)-Cochlearol T, (±)-Ganocochlearin A, and (±)-Cochlearol Y.(±)-耳蜗醇T、(±)-灵芝耳蜗素A和(±)-耳蜗醇Y的化学合成及抗纤维化特性
ACS Med Chem Lett. 2024 Nov 12;15(12):2220-2224. doi: 10.1021/acsmedchemlett.4c00497. eCollection 2024 Dec 12.
2
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Interventions for fatigue and weight loss in adults with advanced progressive illness.针对患有晚期进行性疾病的成年人疲劳和体重减轻的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427. doi: 10.1002/14651858.CD008427.pub2.
5
WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness.撤回:针对晚期进行性疾病成人患者疲劳和体重减轻的干预措施。
Cochrane Database Syst Rev. 2017 Apr 7;4(4):CD008427. doi: 10.1002/14651858.CD008427.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
9
Factors that influence the provision of intrapartum and postnatal care by skilled birth attendants in low- and middle-income countries: a qualitative evidence synthesis.影响低收入和中等收入国家熟练助产士提供产时和产后护理的因素:一项定性证据综合分析
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD011558. doi: 10.1002/14651858.CD011558.pub2.
10
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.

本文引用的文献

1
Total Synthesis of (+)-Cochlearol B by an Approach Based on a Catellani Reaction and Visible-Light-Enabled [2+2] Cycloaddition.基于 Catellani 反应和可见光促进的[2+2]环加成反应策略的 (+)-Cochlearol B 的全合成。
Angew Chem Int Ed Engl. 2022 Aug 1;61(31):e202201213. doi: 10.1002/anie.202201213. Epub 2022 Jun 23.
2
Meroterpenoids containing benzopyran or benzofuran motif from Ganoderma cochlear.灵芝中含苯并吡喃或苯并呋喃母核的倍半萜。
Phytochemistry. 2022 Jul;199:113184. doi: 10.1016/j.phytochem.2022.113184. Epub 2022 Apr 9.
3
Total Synthesis of Cochlearol B via Intramolecular [2+2] Photocycloaddition.通过分子内[2+2]光环加成反应全合成耳蜗醇 B。
Angew Chem Int Ed Engl. 2021 Nov 8;60(46):24484-24487. doi: 10.1002/anie.202110556. Epub 2021 Oct 11.
4
Diastereoselective Formal Synthesis of Polycyclic Meroterpenoid (±)-Cochlearol A.多环倍半萜(±)-耳状醇 A 的非对映选择性形式合成。
J Org Chem. 2021 Apr 2;86(7):5412-5416. doi: 10.1021/acs.joc.1c00205. Epub 2021 Mar 22.
5
Ganoderma lucidum Prevents Cisplatin-Induced Nephrotoxicity through Inhibition of Epidermal Growth Factor Receptor Signaling and Autophagy-Mediated Apoptosis.灵芝通过抑制表皮生长因子受体信号通路和自噬介导的细胞凋亡来预防顺铂诱导的肾毒性。
Oxid Med Cell Longev. 2020 Jul 6;2020:4932587. doi: 10.1155/2020/4932587. eCollection 2020.
6
Renoprotective ganodermaones A and B with rearranged meroterpenoid carbon skelotons from Ganoderma fungi.从真菌灵芝中分离得到的具有重排的混合倍半萜碳骨架的肾保护灵芝酮 A 和 B。
Bioorg Chem. 2020 Jul;100:103930. doi: 10.1016/j.bioorg.2020.103930. Epub 2020 May 14.
7
Divergent Biomimetic Total Syntheses of Ganocins A-C, Ganocochlearins C and D, and Cochlearol T.甘诺菌素 A-C、甘诺耳蜗素 C 和 D 以及耳蜗醇 T 的仿生全合成的差异。
Angew Chem Int Ed Engl. 2020 May 4;59(19):7419-7424. doi: 10.1002/anie.202000677. Epub 2020 Mar 18.
8
Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways.灵芝酸通过抑制 TGF-β/Smad 和 MAPK 信号通路抑制肾纤维化。
Acta Pharmacol Sin. 2020 May;41(5):670-677. doi: 10.1038/s41401-019-0324-7. Epub 2019 Dec 5.
9
Total Synthesis of (±)-Cochlearol A.(±)-耳蜗醇 A 的全合成。
Org Lett. 2019 Sep 6;21(17):6761-6764. doi: 10.1021/acs.orglett.9b02391. Epub 2019 Aug 21.
10
Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling.佩奇替尔 A 通过抑制 TGF-β/Smad3 和 NF-κB 信号通路减轻阻塞性肾病。
J Cell Mol Med. 2019 Aug;23(8):5576-5587. doi: 10.1111/jcmm.14454. Epub 2019 Jun 18.